万维提示：
1、投稿方式：在线投稿。
2、期刊网址：https://academic.oup.com/schizophreniabulletin
3、投稿网址：http://mc.manuscriptcentral.com/szbltn
4、期刊刊期：双月刊，逢单月出版。
2020年12月14日星期一
投稿须知
【官网信息】
Information for Authors
Please note that the journal now encourages authors to complete their license to publish form online
Schizophrenia Bulletin is an international peer-reviewed journal that publishes unsolicited and invited reports and reviews of clinical and experimental research relating to all aspects of schizophrenia. First Person Accounts , Historical perspectives from patients and their families, are also welcome.
Editorial Policies
Manuscripts must be written in English and are accepted for consideration with an explicit understanding that the material has not been previously published in whole or substantial part and is not currently under consideration for publication by any other journal. All matters relating to the editorial policies of Schizophrenia Bulletin should be addressed in writing to Prof. William Carpenter, M.D., Editor-in Chief, Schizophrenia Bulletin Editorial Office, Maryland Psychiatric Research Center, PO Box 21247, Baltimore, MD 21228, USA. Manuscripts should be submitted through the journal's web-based manuscript submission system as instructed below.
Copyright
Schizophrenia Bulletin does not require authors to transfer copyright of their submitted material. Rather, it is a condition of publication in the journal that authors grant an exclusive license to the Maryland Psychiatric Research Center and Oxford University Press. This ensures that requests from third parties to reproduce articles are handled efficiently and consistently and will also allow the article to be as widely disseminated as possible. In assigning the license, authors may use their own material in other publications provided that the Journal is acknowledged as the original place of publication, and that the Maryland Psychiatric Research Center and Oxford University Press are notified in writing and in advance.
Informed Consent and Ethics Committee Approval
Manuscripts reporting experiments on patients or healthy volunteers must record the fact that the subjects' consent was obtained and include a statement that the research was approved by the responsible ethical committee of the institution (e.g., an institutional review board) and was consistent with the principles outlined in an internationally recognized standard for the ethical conduct of human research. Consent must be also recorded when photographs of patients are shown or other details given that could lead to the identification of the individuals. Authors may be required to provide tangible proof that the necessary permissions and consents have been obtained from study participants.
Authorship
The proper assignment of credit and accountability to the intellectual property of a scientific manuscript necessitates a considered approach to the designation of authorship. In general, authors are expected to have been substantially involved in the planning and execution of the study and to have actively participated in the writing or editing of the manuscript. It is essential that all authors acknowledge their approval of the final document prior to submission. In addition to being directly accountable for their own work, authors share in the credit attributed to the published paper and thus implicitly and explicitly indorse the contributions made by their co-authors.
Individuals who have contributed to the manuscript in a meaningful way but do not meet the criteria for authorship, should be identified in the Acknowledgement section of the manuscript.
Team Science and Consortia Authorship
Manuscripts including a consortium of authors will be considered for publication in Schizophrenia Bulletin provided the following criteria are met. First, all members of the consortium that meet the journal’s criteria for authorship must be listed by name in the author byline. Individuals who contributed substantially to the manuscript but do not meet the criteria for authorship must be listed in the Acknowledgements section under the heading “Collaborators” together with their affiliations. Second, it is the obligate responsibility of the corresponding author (CA) to obtain and record assurances from each author that the journal’s conflict of interest policies have been fully satisfied. During submission, the CA will be asked to certify on behalf of all authors that this information has been obtained and properly disclosed. In addition, it is the responsibility of the CA to obtain permission from nonauthor collaborators to be identified as such in the Acknowledgements section.
Laboratory Animals
Manuscripts reporting the results of experiments involving laboratory animals must be contain a statement indicating that the procedures used were in accordance with the guidelines published in the Institute of Laboratory Animals Resources Commission on Life Sciences' 1996 Guide for the Care and Use of Laboratory Animals (Washington, DC: National Academic Press;) or a similar internationally recognized standard. The species, sex, source, and genetic background of the animals as well as a detailed description of the experimental procedures, including any anesthetics and/or analgesics, must be provided in the Methods section of the manuscript.
Manuscripts containing data from human or animal experimentation may be rejected if the ethical aspects are open to question. The corresponding author will be held responsible for false statements or for failure to meet the aforementioned requirements.
Originality
Schizophrenia Bulletin does not publish articles that overlap substantially with articles already published or accepted for publication, whether in print or in the electronic media, even if the new submission contains data not included in the published or accepted work. Schizophrenia Bulletin 's policy is governed by international copyright laws, ethical conduct, and the cost-effective use of resources. Readers of primary-source periodicals trust that the material they are reading is original unless there is a statement that the article is being republished with the knowledge of the author and Editor and the permission of the original copyright holder. This policy does not preclude consideration of a report that follows a presentation at a meeting or expands preliminary findings published or presented as an abstract. A published article that the author thinks may overlap substantially with the manuscript submitted for review should be included with the submission.
By submitting your manuscript to the journal it is understood that this is an original manuscript and is unpublished work not under consideration elsewhere. Plagiarism, including duplicate publication of the author’s own work, in whole or in part without proper citation is not tolerated by the journal. Manuscripts submitted to the journal may be checked for originality using anti-plagiarism software. If an attempt at undisclosed duplicate publication is identified, the article will be rejected, the owners of the copyright will be notified, and the violation may be reported to the
Conflict of Interest
At the point of submission, Schizophrenia Bulletin's policy requires that each author reveal any financial interests or connections, direct or indirect, or other situations that might raise the question of bias in the work reported or the conclusions, implications, or opinions stated - including pertinent commercial or other sources of funding for the individual author(s) or for the associated department(s) or organization(s), personal relationships, or direct academic competition. When considering whether you should declare a conflicting interest or connection please consider the conflict of interest test: Is there any arrangement that would embarrass you or any of your co-authors if it was to emerge after publication and you had not declared it?
Examples of potential conflicts include a proprietary interest in a drug or product mentioned in the study, equity interest in the sponsor of the study or any other commercial entity with a potential financial interest in its outcome, or payments with a cumulative monetary value exceeding $2,000 made by the sponsor to the investigators or their family members during or within two years of the completion of the study. Institutional support for the study should be included in the Acknowledgments section of the manuscript.
Funding
All manuscripts submitted for publication will contain a Conflict of Interest statement. The corresponding author will describe each circumstance in sufficient detail to enable the editors and reviewers to assess its scope and to identify the author(s) with whom the conflict(s) exist. If the corresponding author has indicated that no conflict exists, the following statement will be inserted by the publisher and will appear at the end of the published manuscript:
The sentence should begin: ‘This work was supported by …’
The full official funding agency name should be given, i.e. ‘the National Cancer Institute at the National Institutes of Health’ or simply 'National Institutes of Health', not 'NCI' (one of the 27 subinstitutions) or ‘NCI at NIH’.
Grant numbers should be complete and accurate and provided in parentheses as follows: ‘(grant number xxxx)’
Multiple grant numbers should be separated by a comma as follows: ‘(grant numbers xxxx, yyyy)’
Agencies should be separated by a semi-colon (plus ‘and’ before the last funding agency)
Where individuals need to be specified for certain sources of funding the following text should be added after the relevant agency or grant number 'to [author initials]'.
“The Authors have declared that there are no conflicts of interest in relation to the subject of this study.”
Details of all funding sources for the work in question should be given in a separate section entitled 'Funding'. This should appear before the 'Acknowledgments' section.
The following rules should be followed:
An example is given here: ‘This work was supported by the National Institutes of Health (P50 CA098252 and CA118790 to R.B.S.R.) and the Alcohol & Education Research Council (HFY GR667789).'
Crossref Funding Data Registry
In order to meet your funding requirements authors are required to name their funding sources, or state if there are none, during the submission process. For further information on this process or to find out more about CHORUS, visit the CHORUS initiative.
Manuscript Preparation
All manuscripts are submitted and reviewed via the journal's web-based manuscript submission system accessible at the submission webpage. New authors should create an account prior to submitting a manuscript for consideration.
Manuscripts submitted to Schizophrenia Bulletin should be prepared following the American Medical Association Manual of Style , 10th edition. The manuscript text (including tables) should be prepared using a word processing program and saved as an .rtf or .doc file. Other file formats will not be accepted. Figures must be saved as individual .tif files and should be numbered consecutively (i.e., Figure 1.tif, Figure 2.tif, etc.). The text must be double-spaced throughout and should consist of the sections described below.
Title Page
This page should consist of (i) the complete title of the manuscript, (ii) a running title not to exceed 50 characters including spaces, (iii) the full name of each author and the authors' institutional affiliations, (iv) name, complete address, telephone, fax, and e-mail address of the corresponding author, and (v) separate word counts of the abstract and text body. Please note that there can only be one corresponding author, per journal style
Manuscript Length
Manuscripts should be concisely worded and should not exceed 5,000 words for major reviews, 4,000 words for regular articles, or 2,500 words for invited special features. The word count should include the abstract, text body, figure legends, and acknowledgments and must appear together with the abstract word count on the title page of the manuscript. Supplementary data, including additional methods, results, tables, or figures will be published online.
Abstract
Provide a summary of no more than 250 words describing why and how the study, analysis, or review was done, a summary of the essential results, and what the authors have concluded from the data. The abstract should not contain unexplained abbreviations. Up to six key words that do not appear as part of the title should be provided at the end of the abstract.
Main Text
Unsolicited original manuscripts reporting novel experimental findings should be comprised of these sections, in this order: Abstract, Introduction, Methods, Results, Discussion, Acknowledgments, References, and Figure Legends. Review articles must contain an abstract; however, the body of the text can be organized in a less structured format. Authors of review articles are encouraged to use section headers to improve the readability of their manuscript.
Number pages consecutively beginning with the title page. Spelling should conform to that used in Merriam-Webster's Collegiate Dictionary , eleventh edition. Clinical laboratory data may be expressed in conventional rather than Système International (SI) units.
Acknowledgments
These should be as brief as possible but include the names of sources of logistical support.
References
Authors are encouraged to be circumspect in compiling the reference section of their manuscripts.
Please note: references to other articles appearing in the same issue of the journal must be cited fully in the reference list.
Each reference should be cited in consecutive numerical order using superscript arabic numerals, and reference style should follow the recommendations in the American Medical Association Manual of Style , 10th edition, with one exception: in the reference list, the name of all authors should be given unless there are more than 6, in which case the names of the first 3 authors are used, followed by "et al."
Book: Talairach J, Tournoux P. Co-planar stereotaxic atlas of the human brain . New York, NY: Thieme Medical Publishers; 1998.
Book chapter: Goldberg TE, David A, Gold JM. Neurocognitive deficits in schizophrenia. In: Hirsch SR, Weinberger DR, eds. Schizophrenia . Oxford, England: Blackwell Science; 2003:168-184.
Journal article: Thaker GK, Carpenter WT. Advances in schizophrenia. Nat Med 2001;7:667-671.
Journal article with more than 6 authors: Egan MF, Straub RE, Goldberg TE, et al. Variation in GRM3 affects cognition, prefrontal gluatamate, and risk for schizophrenia. Proc Natl Acad Sci USA 2004;101:12604-12609.
Article published on Advance Access only: Gilad, Y. and Lancet, D. March 5, 2003. Population Differences in the Human Functional Olfactory Repertoire. Mol Biol Evol doi:10.1093/molbev/msg013.
Article first published on Advance Access: Gilad, Y. and Lancet, D. 2003. Population Differences in the Human Functional Olfactory Repertoire Mol Biol Evol 2003;20:307-314. First published on March 5, 2003, doi:10.1093/molbev/msg013.
Journal names should be abbreviated in accordance with Index Medicus.
Manuscripts in which the references do not follow this format will be returned for retyping. References to meeting abstracts, material not yet accepted for publication, or personal communications are not acceptable as listed references and instead should be listed parenthetically in the text. It is the authors' responsibility for obtaining the necessary permissions from colleagues to include their work as a personal communication.
Note : In the online version of Schizophrenia Bulletin there are automatic links from the reference section of each article to cited articles in Medline. This is a useful feature for readers, but is only possible if the references are accurate. It is the responsibility of the author to ensure the accuracy of the references in the submitted article. Downloading references directly from Medline is highly recommended.
Figures and Tables
Full length manuscripts including regular and invited theme articles should contain no more than a combined total of 5 tables and figures. Theme introductions and special features are limited to 2 tables or figures (total). Figures and tables must be referred to using arabic numbers in order of their appearance in the text (e.g., Figure 1, Figure 2, Table 1, Table 2, etc.).
Tables should be created with the table function of a word processing program; spreadsheets are not acceptable. Include only essential data, and format the table in a manner in which it should appear in the text. Each table must fit on a single manuscript page and have a short title that is self-explanatory without reference to the text. Footnotes can be used to explain any symbols or abbreviations appearing in the table. Do not duplicate data in tables and figures.
Please be aware that the figure requirements for initial online submission (peer review) and for reproduction in the journal are different. Initially, it is preferred to embed your figures within the word processing file or upload them separately as low-resolution images (.jpg, .tif, or .gif files). However, upon submission of a revised manuscript, you will be required to supply high-resolution .tif files for reproduction in the journal (1200 d.p.i. for line drawings and 300 d.p.i. for color and half-tone artwork). It is advisable to create high-resolution images first as these can be easily converted into low-resolution images for online submission. Figure legends should be typed separately from the figures in the main text document. Additional information on preparing your figures for publication can be located at Digital Art Suport page.
Wherever possible figures should be submitted in their desired final size, to fit the width of a single (88 mm) or at most a double (180 mm) column width. All letters and numerals appearing in a particular figure should be of the same size and in proportion to the overall dimensions of the drawing. Letter labels used in figures should be in upper case in both the figure and the legend. The journal reserves the right to reduce the size of illustrative material.
Schizophrenia Bulletin is happy to announce the launch of the Flexible Color Option, beginning for all articles accepted after April 13, 2010. All figures submitted to the journal in color will be published in color online at no cost (unless the author specifically requests that their figures be in black and white online). Authors may choose to also publish their figures in color in the print journal for $600/£350/€525 per figure unless a waiver is obtained from the editorial office: you will be asked to approve this cost when you submit your article online. Color figures must have a resolution of at least 300 dots per inch at their final sizes. You will be issued an invoice at the time of publication.
Orders from the UK will be subject to a 17.5% VAT charge. For orders from elsewhere in the EU you or your institution should account for VAT by way of a reverse charge. Please provide us with your or your institution’s VAT number.
Each figure should have a separate legend that clearly identifies all symbols and abbreviations used. The legend should be concise and self-explanatory and should contain enough information to be understood without reference to the text.
Note : All tables and figures reproduced from a previously published manuscript must cite the original source (in the figure legend or table footnote) and be accompanied by a letter of permission from the publisher of record or the copyright owner.
Supplementary Material
Supporting material that is not essential for inclusion in the full text of the manuscript, but would nevertheless benefit the reader, can be made available by the publisher as online-only content, linked to the online manuscript. The material should not be essential to understanding the conclusions of the paper, but should contain data that is additional or complementary and directly relevant to the article content. Such information might include more detailed methods, extended data sets/data analysis, or additional figures (including color). It is standard practice for appendices to be made available online-only as supplementary material. All text and figures must be provided in separate files from the manuscript files labeled as supplementary material in suitable electronic formats (instructions for the preparation of supplementary material can be found on the supplementary material webpage.
All material to be considered as supplementary material must be submitted at the same time as the main manuscript for peer review. It cannot be altered or replaced after the paper has been accepted for publication. Please indicate clearly the material intended as supplementary material upon submission. Also ensure that the supplementary material is referred to in the main manuscript where necessary.
Proofs
Page proofs will be sent to the corresponding author by e-mail as an Acrobat PDF file. The software needed to view this type of file can be downloaded at no charge from Adobe Acrobat Reader DC. Please check text, tables, legends, and references carefully. Proofs must be returned within three days of receipt. The editors and publisher reserve the right to proceed with publication if this period is exceeded. Only typographical errors can be corrected at this stage; substantial changes to the text will not be accepted.
Announcements
Announcements of future meetings, congresses, courses, awards, or other events that are likely to be of interest to the readers of Schizophrenia Bulletin may be submitted to the editorial office for consideration for publication in a future issue. Please provide a brief summary of the nature of the event and the name and e-mail address of a contact person.
Language Editing
Language editing, if your first language is not English, to ensure that the academic content of your paper is fully understood by journal editors and reviewers is optional. Language editing does not guarantee that your manuscript will be accepted for publication. For further information on this service, please visit the Language Services webpage. Several specialist language editing companies offer similar services and you can also use any of these. Authors are liable for all costs associated with such services.
License To Publish Form
Upon receipt of accepted manuscripts at Oxford Journals authors will be invited to complete an online license to publish form.
Please note that by submitting an article for publication you confirm that you are the corresponding/submitting author and that Oxford University Press ("OUP") may retain your email address for the purpose of communicating with you about the article. You agree to notify OUP immediately if your details change. If your article is accepted for publication OUP will contact you using the email address you have used in the registration process. Please note that OUP does not retain copies of rejected articles.
Open Access Option For Authors
Schizophrenia Bulletin authors have the option to publish their paper under the open access initiative ; whereby, for a charge, their paper will be made freely available online immediately upon publication. After your manuscript is accepted the corresponding author will be required to accept a mandatory license to publish agreement. As part of the licensing process you will be asked to indicate whether or not you wish to pay for open access. If you do not select the open access option, your paper will be published with standard subscription-based access and you will not be charged.
Open access articles are published under Creative Commons licenses.
RCUK/Wellcome Trust funded authors publishing in Schizophrenia Bulletin can use the Creative Commons Attribution license (CC BY) for their articles.
All other authors may use the following Creative Commons licenses:
• Creative Commons Attribution Non-Commercial license (CC BY-NC)
• Creative Commons Attribution Non-Commercial No Derivatives license (CC BY-NC-ND)
Visit the OUP licensing website to find out more about Creative Commons licences.
You can pay Open Access charges using our Author Services site. This will enable you to pay online with a credit/debit card, or request an invoice by email or post. The applicable open access charges vary according to which Creative Commons license you select.
Schizophrenia Bulletin offers the option of publishing under either a standard licence or an open access licence. Please note that some funders require open access publication as a condition of funding. If you are unsure whether you are required to publish open access, please do clarify any such requirements with your funder or institution.
Should you wish to publish your article open access, you should select your choice of open access licence in our online system after your article has been accepted for publication. You will need to pay an open access charge to publish under an open access licence.
Details of the open access licences and open access charges.
OUP has a growing number of Read and Publish agreements with institutions and consortia which provide funding for open access publishing. This means authors from participating institutions can publish open access, and the institution may pay the charge. Find out if your institution is participating.
Third-Party Content in Open Access Papers:
If you will be publishing your paper under an Open Access license but it contains material for which you do not have Open Access re-use permissions, please state this clearly by supplying the following credit line alongside the material:
Title of content, author, original publication, year of original publication, by permission of [rights holder]. This image/content is not covered by the terms of the Creative Commons license of this publication. For permission to reuse, please contact the rights holder.
Permissions For Illustrations And Figures
In order to reproduce any third party material, including figures or tables, in an article authors must obtain permission from the copyright holder and be compliant with any requirements the copyright holder may have pertaining to this reuse.
When seeking to reproduce any kind of third party material authors should request the following:
non-exclusive rights to reproduce the material in the specified article and journal;
electronic rights, preferably for use in any form or medium;
the right to use the material for the life of the work; and
world-wide English-language rights.
Further guidelines on clearing permissions can be found at the Access and Purchase Resource Centre.
Authors should also include a statement indicating that permission has been obtained in the relevant legend/footnote and provide the Editorial Office with copies of any relevant paperwork.
A template permissions request letter can be found at the end of the above document.
